NCT06687408 Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques
| NCT ID | NCT06687408 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Lung Cancer, Non-Small Cell |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2025-03-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this multicenter observational study is to evaluate the long-term survival and perioperative outcomes of sleeve lobectomy in robotic-assisted thoracic surgery (RATS) for patients with central lung cancer when compared with video-assisted thoracic surgery (VATS) approach, both of which have been already applied to these patients in minimally invasive surgical techniques as part of their regular medical care recently. The main question it aims to answer is: Are RATS sleeve lobectomy associated with similar or even better long-term survival and perioperative outcomes for patients with central lung cancer when compared with the VATS approach?
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years; * Clinically suspected lung cancer with a high likelihood of undergoing sleeve lobectomy; * Postoperative histopathological diagnosis confirms non-small cell lung cancer (NSCLC); * No history of malignancy within the past 5 years; * Signed informed consent agreeing to participate in this study. Exclusion Criteria: * Unable to undergo surgical resection due to surgical contraindications; * Postoperative pathology does not confirm non-small cell lung cancer (NSCLC), including but not limited to benign lesions, small cell lung cancer, metastatic tumors, or an insufficient or indeterminate histopathology report; * History of malignancy within the past 5 years; * Unable to obtain follow-up data; * Refusal to sign the informed consent or withdrawal of consent.
Contact & Investigator
Haifeng Shen, M.D.
PRINCIPAL INVESTIGATOR
Second Affiliated Hospital, School of Medicine, Zhejiang University
Frequently Asked Questions
Who can join the NCT06687408 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer, Non-Small Cell. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06687408 currently recruiting?
Yes, NCT06687408 is actively recruiting participants. Contact the research team at shenhaifeng@zju.edu.cn for enrollment information.
Where is the NCT06687408 trial being conducted?
This trial is being conducted at Hangzhou, China, Hangzhou, China, Shanghai, China.
Who is sponsoring the NCT06687408 clinical trial?
NCT06687408 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The principal investigator is Haifeng Shen, M.D. at Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 450 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.